Resources

Medicines lifecycle is critical to fostering patient access to innovative therapeutic solutions, and delivering better health outcomes for patients.

Latest resource

Main deliverables

Main deliverable

Sort by
Sort by

D4.2 Code of conduct and guidance for patient engagement in R&D

WP4.2 Co-designed recommendations and resources for patient engagement

21 September, 2020

D4.3 PARADIGM Patient Engagement Toolbox

WP4 – Co-designed recommendations and resources for patient engagement

21 September, 2020

D6.4 Sustainability of the PARADIGM outputs

Patients Active in Research and Dialogues for an Improved Generation of Medicines [WP6 – Sustainability Strategy]

4 September, 2020

D6.3 Refined list of the relevant models addressing sustainability for all stakeholders

Patients Active in Research and Dialogues for an Improved Generation of Medicines WP6 Sustainability Strategy

4 September, 2020

D6.5 Patient Engagement Sustainability Roadmap

Patients Active in Research and Dialogues for an Improved Generation of Medicines (WP6 Sustainability Strategy)

1 September, 2020

THE PARADIGM GAP ANALYSIS

Identifying how existing gaps in patient engagement (PE) can inform the development of appropriate tools and resources for improved and sustainable PE.

17 April, 2020

D2.2 Inventory of gaps in existing patient engagement practices and processes

Patients Active in Research and Dialogues for an Improved Generation of Medicines

3 February, 2020

D2.1 short report of existing patient engagement practices and processes

Patients Active in Research and Dialogues for an Improved Generation of Medicines

20 November, 2019

D7.2 Project Handbook

WP7 – Project Coordination and Management

20 November, 2019